Camera-based monitoring of heart rate, breathing, and oxygen levels in children
Official title: Use of Remote Photoplethysmography to Measure Heart Rate and Respiratory Rate in Pediatrics Compared to Standard Acquisition System: Prospective Comparative Trial
Run by Fondation Lenval · NCT06231654 · Data updated 2026-11-12
This project tests whether a camera-based system can measure heart rate, breathing rate, and oxygen saturation without touching children aged 3 to under 18.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 3 Years to 17 Years |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | Fondation Lenval Academic / other |
| Locations | 1 site (Nice) |
| Status | Recruiting |
| Started | July 2, 2025 |
| Main results expected | July 2, 2026 |
| Study ends | July 2, 2026 |
| Registry record updated | January 28, 2026 |
| Trial ID | NCT06231654 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 3 to under 18 who are visiting or admitted to the participating pediatric hospital and whose parent or guardian can provide informed consent in French are ideal candidates.
✕Probably not a fit
Children with known cardiac arrhythmias, pathological tremors or spasms, scleroderma, neurocognitive disorders, immediate life-threatening conditions, or whose parents do not speak French are excluded and unlikely to benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Remote photoplethysmography (rPPG) uses subtle red-green-blue color changes in the skin captured by a video camera to derive a plethysmographic signal and estimate vital signs. This protocol will record camera video and simultaneously record standard reference measurements (pulse oximeter, ECG or respiratory monitoring) in children seen for any reason at a pediatric hospital. Children who cannot remain sufficiently still, have known arrhythmias, immediate vital distress, neurocognitive disorders, or whose parents do not speak French are excluded. The study aims to compare rPPG-derived heart rate, respiratory rate, and oxygen saturation to conventional devices to determine accuracy and reliability in a pediatric setting.
Why it matters
Potential benefit: If successful, rPPG could allow quick, non-contact vital sign checks that are faster, less distressing for children, and require fewer devices and staff.
How similar studies have gone: In adults, rPPG methods have shown acceptable accuracy compared with standard monitors, but this technique has not been previously studied in pediatric patients.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children under 18 and over 3 years of age * Any reason for consultation or hospitalization * Written and signed informed consent from one parent or the person with parental authority, * Membership of a social security scheme Exclusion Criteria: * Patient with a neurocognitive disorder * Patient in immediate vital distress, * Known cardiac arrhythmia, * Scleroderma * Patients suffering from pathological tremors or muscle spasms that prevent them from remaining static for the duration of the measurement. * Parents who do not understand and/or speak French
Where it's running
-
Fondation Lenval - Hôpitaux Pédiatriques de Nice CHU-LENVAL
Nice, France Recruiting
Study contacts
- Study coordinator: Antoine TRAN, MCU-MD
- Email: antoine.tran@hpu.lenval.com
- Phone: 04-92-03-04-42
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.